Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.02 Billion EUR | -4.83% |
| 2022 | 1.07 Billion EUR | 11.05% |
| 2021 | 969.58 Million EUR | 24.26% |
| 2020 | 780.29 Million EUR | -16.9% |
| 2019 | 939.03 Million EUR | 3.11% |
| 2018 | 910.74 Million EUR | -12.03% |
| 2017 | 1.03 Billion EUR | -17.37% |
| 2016 | 1.25 Billion EUR | -2.04% |
| 2015 | 1.27 Billion EUR | 8.51% |
| 2014 | 1.17 Billion EUR | 5.1% |
| 2013 | 1.12 Billion EUR | -4.57% |
| 2012 | 1.17 Billion EUR | 6.66% |
| 2011 | 1.1 Billion EUR | 2.03% |
| 2010 | 1.07 Billion EUR | 6.79% |
| 2009 | 1.01 Billion EUR | -11.9% |
| 2008 | 1.14 Billion EUR | -3.58% |
| 2007 | 1.19 Billion EUR | 6.1% |
| 2006 | 1.12 Billion EUR | 9.43% |
| 2005 | 1.02 Billion EUR | 8.52% |
| 2004 | 944.74 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 569.78 Million USD | 0.0% |
| 2023 FY | 1.02 Billion EUR | -4.83% |
| 2023 Q4 | 523.82 Million USD | 120.75% |
| 2023 Q3 | 237.29 Million EUR | -60.45% |
| 2023 Q2 | 600.05 Million USD | 118.15% |
| 2023 Q1 | 275.06 Million EUR | -49.19% |
| 2022 Q2 | 285.44 Million USD | 0.0% |
| 2022 Q4 | 541.39 Million USD | 114.05% |
| 2022 FY | 1.07 Billion EUR | 11.05% |
| 2022 Q1 | 285.44 Million EUR | 24.41% |
| 2022 Q3 | 252.93 Million EUR | -11.39% |
| 2021 Q3 | 229.43 Million EUR | -10.15% |
| 2021 Q2 | 255.36 Million USD | 0.0% |
| 2021 FY | 969.58 Million EUR | 24.26% |
| 2021 Q1 | 255.36 Million EUR | 14.84% |
| 2021 Q4 | 229.43 Million USD | 0.0% |
| 2020 Q3 | 222.35 Million EUR | 32.52% |
| 2020 FY | 780.29 Million EUR | -16.9% |
| 2020 Q1 | 167.79 Million EUR | -24.27% |
| 2020 Q2 | 167.79 Million USD | 0.0% |
| 2020 Q4 | 222.35 Million USD | 0.0% |
| 2019 Q3 | 221.55 Million EUR | -60.77% |
| 2019 Q1 | 247.96 Million EUR | 11.44% |
| 2019 FY | 939.03 Million EUR | 3.11% |
| 2019 Q2 | 564.75 Million EUR | 127.76% |
| 2019 Q4 | 221.55 Million USD | 0.0% |
| 2018 Q3 | 222.5 Million EUR | -4.45% |
| 2018 Q4 | 222.5 Million EUR | 0.0% |
| 2018 FY | 910.74 Million EUR | -12.03% |
| 2018 Q1 | 232.86 Million EUR | -4.59% |
| 2018 Q2 | 232.86 Million EUR | 0.0% |
| 2017 Q1 | 273.59 Million EUR | -9.08% |
| 2017 Q4 | 244.07 Million EUR | 0.0% |
| 2017 Q3 | 244.07 Million EUR | -10.79% |
| 2017 FY | 1.03 Billion EUR | -17.37% |
| 2017 Q2 | 273.59 Million EUR | 0.0% |
| 2016 FY | 1.25 Billion EUR | -2.04% |
| 2016 Q2 | 325.55 Million EUR | 0.0% |
| 2016 Q4 | 300.91 Million EUR | 0.0% |
| 2016 Q3 | 300.91 Million EUR | -7.57% |
| 2016 Q1 | 325.55 Million EUR | 1.98% |
| 2015 FY | 1.27 Billion EUR | 8.51% |
| 2015 Q4 | 319.22 Million EUR | 12.08% |
| 2015 Q3 | 284.81 Million EUR | -18.77% |
| 2015 Q2 | 350.62 Million EUR | 8.12% |
| 2015 Q1 | 324.3 Million EUR | 4.23% |
| 2014 Q1 | 293.2 Million EUR | 4.8% |
| 2014 Q4 | 311.13 Million EUR | 19.09% |
| 2014 Q3 | 261.26 Million EUR | -16.55% |
| 2014 Q2 | 313.08 Million EUR | 6.78% |
| 2014 FY | 1.17 Billion EUR | 5.1% |
| 2013 FY | 1.12 Billion EUR | -4.57% |
| 2013 Q2 | 301.34 Million EUR | 1.46% |
| 2013 Q4 | 279.76 Million EUR | 14.94% |
| 2013 Q1 | 297.01 Million EUR | -5.09% |
| 2013 Q3 | 243.4 Million EUR | -19.23% |
| 2012 Q1 | 288.72 Million EUR | 7.57% |
| 2012 Q3 | 249.07 Million EUR | -23.26% |
| 2012 Q4 | 312.93 Million EUR | 25.64% |
| 2012 FY | 1.17 Billion EUR | 6.66% |
| 2012 Q2 | 324.56 Million EUR | 12.41% |
| 2011 Q2 | 302.59 Million EUR | 0.64% |
| 2011 Q4 | 268.39 Million EUR | 16.57% |
| 2011 FY | 1.1 Billion EUR | 2.03% |
| 2011 Q3 | 230.23 Million EUR | -23.91% |
| 2011 Q1 | 300.66 Million EUR | 14.87% |
| 2010 Q2 | 294.35 Million EUR | 2.93% |
| 2010 FY | 1.07 Billion EUR | 6.79% |
| 2010 Q3 | 237.85 Million EUR | -19.19% |
| 2010 Q1 | 285.97 Million EUR | 20.9% |
| 2010 Q4 | 261.75 Million EUR | 10.05% |
| 2009 Q1 | 287.9 Million EUR | 0.0% |
| 2009 FY | 1.01 Billion EUR | -11.9% |
| 2009 Q4 | 236.53 Million EUR | 11.28% |
| 2009 Q3 | 212.55 Million EUR | -22.49% |
| 2009 Q2 | 274.23 Million EUR | -4.75% |
| 2008 FY | 1.14 Billion EUR | -3.58% |
| 2007 FY | 1.19 Billion EUR | 6.1% |
| 2006 FY | 1.12 Billion EUR | 9.43% |
| 2005 FY | 1.02 Billion EUR | 8.52% |
| 2004 FY | 944.74 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -32008.424% |
| Ansell Limited | 1.61 Billion USD | 36.718% |
| Ansell Limited | 1.61 Billion USD | 36.718% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -454.967% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -758651.62% |
| Psykey, Inc. | 419.29 Thousand USD | -244291.711% |
| ConvaTec Group Plc | 2.19 Billion USD | 53.294% |
| ConvaTec Group Plc | 2.14 Billion USD | 52.169% |
| Encision Inc. | 6.58 Million USD | -15459.526% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -56052.006% |
| LifePoint, Inc. | -18.5 Thousand USD | 5539191.892% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -14940.834% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -132637.306% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -103805.011% |
| Reflect Scientific, Inc. | 1.08 Million USD | -94769.065% |
| SmileDirectClub, Inc. | 470.74 Million USD | -117.684% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 45.249% |
| SheerVision, Inc. | 3.49 Million USD | -29183.019% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -73818.808% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -137430.751% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -982545.302% |